AlphAIalphai — Financial news for AI agents
BenzingaNOV 124 min read$BHVN

FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Biohaven (NYSE:BHVN), Dingdong (Cayman) (NYSE:DDL)

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Wednesday. Shares of FLEX LNG Ltd ( NYSE:FLNG ) fell sharply in pre-market trading following weaker-than-expected quarterly earnings.

Original reporting
Benzinga · Avi Kapoor
Published Nov 12, 2025, 1:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 12, 2025, 2:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Biohaven (NYSE:BHVN), Dingdong (Cayman) (NYSE:DDL) — source image
Source · www.benzinga.com
Decision brief

The 30-second read

$BHVNBearishMed
01

Why it matters

The decline in specific stocks like Biohaven and Dingdong reflects investor caution, which could spill over into related sectors.

02

Market read

The current news highlights sector-specific challenges affecting biotech, energy, and tech stocks, with potential ripple effects across related markets.

03

What to watch

Market volatility, macroeconomic data releases, and sector-specific catalysts could influence stock movements beyond current analysis.

Timing: short-term (next few trading sessions)

Background

The market is experiencing volatility due to earnings season, with some stocks moving lower amid disappointing quarterly results.

Company-level read

Ticker impact

$BHVNBearishMedium confidence
Context

Moderately relevant due to recent decline and sector implications.

Expected impact

Short-term downward pressure expected, with a possible rebound if fundamentals improve.

Evidence & confidence

Weak earnings and pre-market decline suggest bearish sentiment; however, broader market conditions and sector performance could influence the actual movement.

$DDLBearishMedium confidence
Context

Moderately relevant; stock moving lower in pre-market, indicating sector or company-specific issues.

Expected impact

Potential continued decline in the short term, with support levels to watch for possible reversal.

Evidence & confidence

Pre-market decline indicates bearish sentiment; technical support levels and upcoming news could alter the trend.

$FLNGNeutralMedium confidence
Context

Moderately relevant; neutral sentiment with limited immediate impact.

Expected impact

Likely sideways trading in the near term.

Evidence & confidence

Relevance score suggests limited impact; technical levels and market conditions will influence movement.

Market effects

Sector

Weak earnings reports from energy, biotech, and tech sectors may lead to broader sector adjustments.

Regional

Potential regional impacts in sectors with high exposure to the affected companies.

Global

Limited; primarily regional and sector-specific effects.

Counterpoint

What could challenge this read

Weak earnings may be temporary, and stocks could rebound if broader market sentiment improves.

Key entities

  • Biotech Company
    Biohaven

    A biopharmaceutical company focused on central nervous system disorders.

  • E-commerce/Logistics Company
    Dingdong (Cayman)

    A company involved in e-commerce logistics and retail services.

  • Energy Company
    Flex LNG Ltd

    A provider of liquefied natural gas shipping services.

  • Automotive Company
    Rivian

    An electric vehicle manufacturer.

  • Automotive Company
    Xpeng (XPEV)

    An electric vehicle manufacturer based in China.

Read at source← All news

Related articles

MAY 27
$BHVNMedAI 8/10

Biohaven (NYSE:BHVN) Stock Price Up 9% – Should You Buy?

Biohaven Ltd. (NYSE:BHVN) rose about 9% mid-day Wednesday to around $10.97, after closing at $10.07. Shares traded as high as $10.95; volume was 864,521 shares, down 63% from average. Analysts cited include Citigroup’s $17 target and Canaccord’s $21; consensus target is $22.27. Biohaven reported Q1 EPS of -$0.88, slightly worse than -$0.86.

dailypolitical.com4 min
AUG 9
$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

baystreet.ca3 min
AUG 9
$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

tradearabia.com3 min
AUG 9
$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

globes.co.il4 min
AUG 9
$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

ua.news5 min